7-27-12-Merck (NYSE:MRK) reported Q2 EPS of $1.05, beating estimates by $0.03. Revenues in the quarter rose 1% year-over-year to $12.3 billion, beating estimates by $140 million. The company still sees 2012 adjusted EPS of $3.75-$3.85, vs. estimates of $3.83. Merck also reiterated annual revenue at or near 2011 levels with constant FX. At current exchange rates, sales would be hurt by about 6% in Q3, 3% for the year.
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up